Russian Olive Allergy Shots: Oleaceae Cross-Reactivity Across Family Lines
Russian olive allergy shots (SCIT) address a diagnostic curveball: Elaeagnus angustifolia belongs to a completely different botanical family from olive (Elaeagnaceae, not Oleaceae), yet it cross-reacts with olive IgE at r=0.77 and tests SPT-positive in 30.5% of rhinoconjunctivitis patients (Sastre 2004, Allergy). No IUIS-named allergen exists.
About Curex’s SCIT program
Curex’s at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- • Pollens — tree, grass, weed & ragweed
- • Pet dander — cat & dog
- • Dust mites
- • Molds — Alternaria & mold mix
Russian Oliveis covered here for general education and may not be part of Curex’s current treatment set. Join the waitlist and our care team will help confirm your options.
Russian Olive Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to russian olive — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of russian olive allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of russian olive immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of russian olive extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for russian olive allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
- Or at home with no clinic visits— Curex’s Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing russian olive extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription russian olive immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat russian olive allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Russian Olive?
The biology, taxonomy, and clinical fingerprint of Russian Olive — the foundation of how SCIT targets it.
Elaeagnus angustifolia (Russian olive) in May bloom in the Intermountain West, where it is a widespread invasive. Though primarily insect-pollinated, detectable airborne pollen drives clinical sensitization in 30.5% of tested rhinoconjunctivitis patients.
- Scientific name
- Elaeagnus angustifolia
- Family
- ElaeagnaceaeOleaster family
- Type
- Late-spring tree pollen (primarily insect-pollinated, with detectable airborne pollen)
- Native to
- Central Asia and southern Europe; widely naturalized throughout most of the United States except the Southeast; planted as ornamental and windbreak
- Allergen proteins
- No IUIS-named allergen as of 2025 (allergen.org) — WHO/IUIS does not list any Elaeagnaceae allergensOle e 1-like IgE-binding band (~63.7 kDa) identified — Sastre J et al., Allergy 2004Ole e 4-like IgE-binding band (~43 kDa) identified — Sastre J et al., Allergy 2004Note: These are characterized IgE-binding proteins, not yet formally submitted to IUIS for naming
- Particle size
- ~20–25 μm (approximate; Russian olive is primarily insect-pollinated, airborne pollen present at lower concentrations than wind-pollinated trees)
- Avoidance difficulty
- Very difficult
How Russian Olive Allergy Presents
Symptoms by body system — useful for distinguishing Russian Olive sensitivity from overlapping allergies and infections.
Respiratory
- Nasal congestion and rhinorrhea during May–June pollen release in Russian olive-naturalized regions
- Sneezing episodes near Russian olive plantings during late spring bloom
- Asthma exacerbations in olive-sensitized patients with concurrent Russian olive exposure
- Persistent postnasal drip during the May–June Oleaceae cross-reactive window
Ocular
- Bilateral allergic conjunctivitis during Russian olive bloom in the Intermountain West
- Eye watering and itching during May–June outdoor exposure
- Periorbital edema on high-pollen days near dense Russian olive stands
Dermal
- Contact urticaria from handling Russian olive branches or foliage
- Generalized skin itching during high-concentration outdoor exposures
- Eczema flares in olive-sensitized atopic patients during the late spring window
Systemic
- Fatigue from sustained May–June Oleaceae exposure in the Intermountain West and Plains
- Sleep disruption from nocturnal nasal blockage during bloom season
- Headache from sinus pressure coinciding with late spring exposure
- Reduced quality of life during late spring outdoor activity peak
Russian olive is the clearest example in tree-pollen practice of why protein family matters more than botanical family. A patient who tests positive to olive should be assumed to react to Russian olive in their environment — even though the two plants aren't related taxonomically. The r=0.77 IgE correlation from Sastre 2004 is among the strongest cross-family cross-reactivities documented anywhere in the allergen literature.
When & Where Russian Olive Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: May–June; Russian olive is primarily insect-pollinated, so airborne pollen concentrations are lower than wind-pollinated trees, but sufficient for clinical sensitization· ~6–8 weeks of detectable airborne pollen; intensity varies by local planting density
US Exposure Map
7 high-intensity statesExposure intensity by state (text version)
- ME:
- Low
- VT:
- Low
- NH:
- Low
- WA:
- Moderate
- MT:
- Moderate
- ND:
- Moderate
- MN:
- Low
- WI:
- Low
- MI:
- Low
- NY:
- Low
- MA:
- Low
- OR:
- Moderate
- ID:
- High
- WY:
- High
- SD:
- Moderate
- IA:
- Low
- IL:
- Low
- IN:
- Low
- OH:
- Low
- PA:
- Low
- NJ:
- Low
- CT:
- Low
- RI:
- Low
- CA:
- Moderate
- NV:
- High
- UT:
- High
- CO:
- High
- NE:
- Moderate
- MO:
- Low
- KY:
- Low
- WV:
- Low
- VA:
- Low
- MD:
- Low
- DE:
- Low
- AZ:
- High
- NM:
- High
- KS:
- Moderate
- AR:
- Low
- TN:
- Low
- NC:
- Low
- SC:
- Low
- OK:
- Moderate
- LA:
- Low
- MS:
- Low
- AL:
- Low
- GA:
- Low
- TX:
- Moderate
- FL:
- Low
- AK:
- Low
- HI:
- Low
What Russian Olive Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Russian olive's cross-reactivity with true olive is a striking example of protein-family convergence across botanical family lines. Despite being Elaeagnaceae rather than Oleaceae, Russian olive expresses Ole e 1-like (~63.7 kDa) and Ole e 4-like (~43 kDa) IgE-binding proteins that produce an r=0.77 IgE correlation with olive-allergic sera (Sastre 2004) — the highest cross-family cross-reactivity documented in the tree-pollen literature.
r=0.77 IgE correlation; 30.5% of rhinoconjunctivitis patients SPT+ to Russian olive (Sastre 2004, Allergy)
Ole e 1-like cross-reactivity extends to ash via shared Fra e 1 / Ole e 1-like protein family (Sastre 2004)
Is SCIT Right for Your Russian Olive Allergy?
Answer five questions to assess whether Russian olive SCIT is right for your late-spring allergy profile.
How severe are your late-spring (May–June) allergy symptoms in Russian olive-naturalized regions?
The Russian Olive SCIT Protocol
Russian olive SCIT is typically anchored to olive extract (Ole e 1) given the 30.5% co-sensitization and r=0.77 IgE correlation. No Russian olive-specific extract standardization exists; your allergist will use the olive SCIT protocol with the addition of Russian olive extract if available and clinically warranted.
Dose escalation from the most dilute vial. Olive-anchored SCIT is the primary approach given the r=0.77 IgE correlation with olive and the absence of a separate Russian olive extract standard. Your allergist may include Russian olive in the multi-allergen formulation if regional exposure warrants. Traditionally each injection was followed by a 30-minute observation period in the clinic; with Curex, eligible patients self-administer the same escalation schedule at home, and the first injection from each new vial or concentration is supervised live in the Virtual Shot Room with a prescribed epinephrine auto-injector confirmed on hand.
Olive-anchored maintenance injections provide Ole e 1-like tolerance that cross-protects Russian olive via shared protein family. Immunologic markers shift over 12–18 months. With Curex these maintenance doses are self-administered at home, and a 30-minute self-observation continues throughout, with any changes to a new vial or concentration supervised live in the Virtual Shot Room.
After completing 3–5 years, your allergist assesses durable tolerance. Cross-protection to Russian olive via Ole e 1-like mechanism should persist alongside tolerance to the primary olive extract.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Russian Olive SCIT
Russian olive-specific SCIT has no published randomized controlled trial. The evidence base is entirely derived from Sastre 2004 (cross-reactivity characterization) and the olive AIT literature (Pareja 2015 AVANZ trial), extrapolated via the r=0.77 Ole e 1-like cross-reactivity correlation.
- IgE correlation with olive-allergic sera (r value)77%Sastre J, Lluch-Bernal M, Quirce S, et al. Allergy 2004 — r=0.77 IgE correlation; 30.5% (73/134) SPT+ in rhinoconjunctivitis/asthma patients
- SPT-positive rate in rhinoconjunctivitis patients (Sastre 2004)30%Sastre J, et al. Allergy 2004 — 30.5% of 134 tested rhinoconjunctivitis/asthma patients SPT+ to Russian olive
- AVANZ olive SCIT tolerability and immunologic response68%Pareja L, et al. Allergol Immunopathol (Madr) 2015 — AVANZ olive SCIT confirmed as foundation for Oleaceae cross-protection mechanism
No randomized controlled trial for Russian olive-specific SCIT exists as of 2025. The honest evidence summary: Russian olive has NO IUIS-named allergen, is primarily insect-pollinated (with detectable airborne pollen), and is characterized solely by Sastre 2004 and subsequent Ole e 1-like cross-reactivity data. Olive-anchored SCIT provides theoretical cross-protection via the shared Ole e 1-like protein family, but no direct clinical trial has validated this extrapolation for Russian olive specifically. A board-certified allergist should weigh this evidence gap transparently with the patient.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Russian Olive SCIT Side Effects
Russian olive SCIT (typically olive-anchored) carries the standard inhalant immunotherapy side-effect profile — local injection-site reactions are expected during build-up; serious systemic reactions are rare.
Local reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Injection-site swelling Expected wheal and flare; resolves within 30–60 minutes | Rate 30–50% | Mild |
Injection-site itching Localized pruritus managed with cold compress or pre-injection antihistamine | Rate 25–40% | Mild |
Large local reaction Swelling >5 cm lasting >24 hours; requires dose adjustment per JTF 2023 | Rate 5–10% | Moderate |
Delayed local induration Firm nodule for 1–3 days; resolves spontaneously | Rate 3–8% | Mild |
Systemic reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Rhinitis or conjunctivitis flare Sneezing or eye watering within 30 minutes post-injection; self-limiting | Rate 1–3% | Mild |
Mild urticaria Generalized hives without systemic compromise; requires dose reduction | Rate 0.5–1% | Moderate |
Mild asthma exacerbation Bronchospasm during build-up; pre-injection spirometry standard for asthmatic patients | Rate 0.1–0.5% | Moderate |
Anaphylaxis Managed immediately with epinephrine; with Curex the first injection from each new vial or concentration is supervised live in the Virtual Shot Room and a prescribed epinephrine auto-injector is confirmed on hand, with onset typically within 30 minutes | Rate <0.1% per injection | Severe |
Russian olive serum is sterile-compounded to USP <797>, and with Curex the first injection from each new vial or concentration is supervised live in the Virtual Shot Room with a prescribed epinephrine auto-injector confirmed on hand. A 30-minute self-observation captures the vast majority of systemic reactions (Greenhawt et al., Ann Allergy Asthma Immunol 2023).
SCIT vs Alternatives for Russian Olive
Intermountain West patients with Russian olive allergy have four options: SCIT (olive-anchored cross-protection) — now available as a weekly at-home injection with Curex — sublingual drops, avoidance of dense Russian olive stands, or antihistamines and nasal steroids during May–June.
| Criterion | SCITBest | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Theoretical via olive-anchored Ole e 1-like cross-protection (Sastre 2004); no species-specific RCT | Emerging evidence; Ole e 1-based drops cross-protect via same Ole e 1-like mechanism | Partial — Russian olive is a widespread invasive; riparian thickets hard to avoid | Good for mild-moderate May–June AR; adequate for most patients |
| 5-yr cost | $3,500–$15,000 over 5 years | Varies by provider; sold as a general sublingual modality, not Curex's product | Low direct cost; moderate lifestyle burden during May–June | $300–$1,200/year for prescriptions |
| Duration | 3–5 years weekly then monthly | 3–5 years daily drops | Seasonal vigilance required | Lifelong seasonal use |
| Convenience | At-home weekly self-injection with Curex for ~6 months, then monthly; the first injection from each new vial or concentration supervised live in the Virtual Shot Room | At-home; no clinic visits needed | HEPA filtration indoors helpful; outdoor avoidance near riparian zones impractical | Convenient daily antihistamines and nasal steroids |
| Safety | Excellent; rare systemic reactions with observation | Lower systemic reaction risk than SCIT | No treatment risk; no disease modification | Well-established safety profile |
| Lasting effect | Years of lasting benefit after completing course | Duration of benefit still being studied | No lasting benefit; symptoms return each May–June | No lasting benefit; symptoms return when medications stop |
SCITBest
SLIT
Avoidance
Medications
For confirmed Oleaceae-sensitized patients with Russian olive co-exposure in the Intermountain West, olive-anchored SCIT addresses both olive and Russian olive cross-reactivity in a single course. At-home IgE testing identifies Oleaceae sensitization and Russian olive co-exposure patterns, and Curex now delivers that SCIT as a weekly at-home injection with pricing confirmed in a current program quote — the serum is sterile-compounded to USP <797>, the first injection from each new vial or concentration is supervised live in the Virtual Shot Room, and a prescribed epinephrine auto-injector is confirmed on hand — providing the same Ole e 1-like cross-protection without the clinic-visit schedule.
What Russian Olive SCIT Actually Costs
SCIT for Russian olive cross-reactivity is typically covered under standard allergy benefits when olive sensitization is confirmed and clinically documented. Since Russian olive lacks a named allergen, the prescription may be anchored to olive SCIT with Russian olive as a co-trigger in the clinical narrative. Out-of-pocket cost depends on your plan's deductible and co-insurance. Curex at-home IgE testing identifies specific russian olive sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; consultations are included without copay. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistStop guessing about your russian olive allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Russian Olive SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Russian olive (Elaeagnus angustifolia) belongs to the Elaeagnaceae family — a different botanical family from true olive (Olea europaea, Oleaceae). Despite this, Russian olive expresses Ole e 1-like IgE-binding proteins (~63.7 kDa and ~43 kDa bands characterized by Sastre 2004, Allergy) that produce an r=0.77 IgE correlation with olive-allergic sera and SPT-positivity in 30.5% of rhinoconjunctivitis/asthma patients tested. This cross-reactivity is the strongest cross-family cross-reactivity documented in the tree-pollen literature — a striking example of convergent protein evolution where different plant families independently evolved similar secretory proteins that happen to be recognized by the same IgE antibodies.
No — Russian olive (Elaeagnus angustifolia) has no IUIS-named allergen as of 2025 (allergen.org). The WHO/IUIS Allergen Nomenclature Sub-Committee has not formally registered any Elaeagnaceae allergens. The cross-reactive proteins — an Ole e 1-like band at ~63.7 kDa and an Ole e 4-like band at ~43 kDa — were characterized by IgE immunoblotting and documented in Sastre 2004 (Allergy), but have not been purified, sequenced, and submitted for formal IUIS naming. This is an honest evidence gap: Russian olive is clinically relevant by immunologic data but molecularly uncharacterized to the IUIS standard.
No — Russian olive (Elaeagnus angustifolia, Elaeagnaceae) and salt cedar (Tamarix ramosissima, Tamaricaceae) are completely different invasive plants that share some geographic range in the Southwest but belong to unrelated botanical families with different allergen profiles. Russian olive cross-reacts strongly with olive via Ole e 1-like proteins (r=0.77 per Sastre 2004). Salt cedar has no named allergen and very limited cross-reactivity data. Both are Southwest invasives, but their immunologic significance and treatment rationale are entirely distinct. A board-certified allergist can distinguish them with species-specific skin testing.
Theoretically yes — the r=0.77 IgE correlation between olive and Russian olive (Sastre 2004) suggests that Ole e 1 tolerance built through olive SCIT should provide cross-protection against Russian olive's Ole e 1-like proteins. However, no clinical trial has directly tested this extrapolation for Russian olive specifically. The cross-protection mechanism is biologically plausible and is the same principle that applies to ash (Fra e 1 / Ole e 1 88% identity) and privet (Lig v 1 / Ole e 1 91% identity). A board-certified allergist can assess whether your olive-SCIT response, combined with your regional Russian olive exposure, suggests additional extract adjustment is needed.
Russian olive (Elaeagnus angustifolia) is naturalized throughout most of the United States except the Southeast — it is particularly dense as a riparian invasive in the Intermountain West (Utah, Colorado, Wyoming, New Mexico, Arizona, Nevada, Idaho), the Northern Plains (North Dakota, South Dakota, Nebraska, Kansas), and parts of California. It was originally planted as a windbreak and ornamental, then naturalized aggressively along rivers and streams where it outcompetes native cottonwood and willow. The US Department of Agriculture lists it as invasive in most western states. Pollen release occurs in May–June, overlapping with late spring tree pollen season.
Yes — antihistamines can be continued throughout SCIT for Russian olive co-sensitization. Your allergist may recommend taking an antihistamine on injection days during early build-up to reduce local reactions. Nasal corticosteroid sprays can also be maintained. As Ole e 1-like tolerance develops over 12–18 months, most patients notice reduced need for rescue medications during the May–June exposure window. Do not abruptly stop antihistamines — taper under your allergist's guidance as tolerance improves.
Russian olive is classified as primarily insect-pollinated (entomophilous) — it has fragrant flowers that attract insects. However, 'primarily insect-pollinated' does not mean airborne pollen is absent. Dense stands of Russian olive in riparian zones produce enough detectable airborne pollen in May–June to cause clinical sensitization, as documented by the 30.5% SPT-positivity rate in Sastre 2004 (Allergy). This is different from obligate entomophilous plants (like Joshua tree) where pollen is packaged by insects and virtually no pollen escapes into the air. Russian olive is a borderline case — its sensitization data are real but its airborne pollen concentrations are lower than wind-pollinated trees like ash or cedar.
Yes — if you test positive for olive IgE and live in or regularly visit Russian olive-naturalized regions (Intermountain West, Plains, parts of California), asking your allergist to include Russian olive in your evaluation is clinically reasonable. The r=0.77 IgE correlation (Sastre 2004) means that most olive-allergic patients are co-sensitized to Russian olive, and Russian olive exposure in late spring (May–June) may be contributing to symptoms that an olive-only treatment plan partially misses. Conversely, if you test positive to Russian olive but not to olive, your allergist may still anchor SCIT to olive given the molecular cross-reactivity basis and absence of Russian olive-specific extract characterization.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.